Market Tracker

11/21 6:05pm ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

102.90
Data as of Nov 21
 +2.47 / +2.46%
Today’s Change
82.52
Today|||52-Week Range
172.98
+14.41%
Year-to-Date

Today’s Trading

Previous close100.43
Today’s open101.72
Day’s range100.02 - 103.62
Volume3,241,139
Average volume (3 months)2,563,085
Market cap$6.4B
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+42.78%
Earnings growth (next 5 years)+19.50%
Revenue growth (last year)+26.98%
P/E ratioNM
Price/Sales5.95
Price/Book8.53

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-1.17-0.81%
UTHRUnited Therapeutics ...+0.25+0.19%
PBYIPuma Biotechnology I...+2.36+1.06%
IDXXIDEXX Laboratories I...-0.11-0.07%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$1.17
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Senior VP-Finance &
Administrative Services
Timothy J. Creech
Corporate headquarters
Raleigh, North Carolina

Forecasts